AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 31617568
Drug: 2-dose (2D)
RxNorm normalized name: Hep A, ped/adol, 2 dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2-dose (2D) quadrivalent HPV vaccine
Trial: 31617568
Drug: 3-dose (3D)
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: 3-dose (3D) quadrivalent HPV vaccine in women aged 16-26
Trial: 18188711
Drug: rhEPOalpha treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: rhEPOalpha treatment (n = 50)
Trial: 18188711
Drug: EPO receptor
RxNorm normalized name: epoetin alfa
DrugBank: Erythropoietin (DB00016)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: EPO receptor protein expression
Trial: 12612902
Drug: Medical therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medical therapy plus TIPS
Trial: 8740106
Drug: Miconazole oral
RxNorm normalized name: miconazole Oral Gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Miconazole oral gel (Daktar, Janssen)
Trial: 8740106
Drug: Nystatin oral
RxNorm normalized name: nystatin Oral Tablet
DrugBank: Nystatin (DB00646)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nystatin oral gel (Candio‐Hermal)
Trial: 8740106
Drug: Nystatin oral
RxNorm normalized name: nystatin Oral Tablet
DrugBank: Nystatin (DB00646)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Nystatin oral gel (Lederlind)
Trial: 1831972
Drug: Cognitive treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive treatment (with or without relaxation training)
Trial: 6129364
Drug: Reduced daily
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Reduced daily salt intake from 192 mmol to 77 mmol
Trial: 11573752
Drug: Medical Nutrition
RxNorm normalized name: Ocean Blue Nutritionals Omega-3 1450 Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medical Nutrition Therapy (MNT)
Trial: 22261362
Drug: Very accelerated
RxNorm normalized name: Primula veris extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Very accelerated radiotherapy (64·8 Gy [1·8 Gy twice daily] in 3·5 weeks)
Trial: 6614128
Drug: Neurodevelopmental treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Neurodevelopmental treatment (NDT)
Trial: 16495471
Drug: Selenium supplementation
RxNorm normalized name: Selenium supplements
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Selenium supplementation (200 microg daily)
Trial: 8873109
Drug: High-dose UL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose UL ECT (three times the threshold)
Trial: 8873109
Drug: Low-dose UL
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose UL ECT (threshold)
Trial: 1505422
Drug: Daily brushing
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily brushing (96% reported brushing daily)
Trial: 31650861
Drug: Nutritional supplement
RxNorm normalized name: Nutritional supplement
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nutritional supplement adherence
Trial: 31409380
Drug: CNS-focused treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CNS-focused treatment program
Trial: 31409380
Drug: Standard medical
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard medical and physical therapy care
Trial: 22751874
Drug: Cholecalciferol (vitamin
RxNorm normalized name: cholecalciferol (vitamin D3)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cholecalciferol (vitamin D3) 2000 IU daily
Trial: 3313101
Drug: Azathioprine with
RxNorm normalized name: Azathioprine
DrugBank: Azathioprine (DB00993)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Azathioprine with steroids
Trial: 22728026
Drug: nab-paclitaxel 150
RxNorm normalized name: Paclitaxel
DrugBank: Paclitaxel (DB01229)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: nab-paclitaxel 150 mg/m(2) qw 3/4
Trial: 17684468
Drug: Chromium picolinate
RxNorm normalized name: Chromium Picolinate
DrugBank: Chromium picolinate (DB11255)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Chromium picolinate and biotin combination (600 microg chromium as chromium picolinate and 2 mg biotin)
Trial: 9577944
Drug: Intracoronary (IC)
RxNorm normalized name: HELIUM 992 mL in 1 L INTRACORONARY GAS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intracoronary (IC) enalaprilat (0.05 mg/min for 15 minutes)
Trial: 9577944
Drug: Sublingual (SL)
RxNorm normalized name: Sublingual Film
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sublingual (SL) captopril (25 mg)
Trial: 8588830
Drug: Syncroner (2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Syncroner (2 puffs of 2 mg 4 times a day for two weeks)
Trial: 8588830
Drug: Standard mouthpiece
RxNorm normalized name: BREATHING CIRCUIT W/MOUTHPIECE,STANDARD
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard mouthpiece (2 puffs of 2 mg 4 times a day for two weeks)
Trial: 46712
Drug: Progesterone-releasing devices
RxNorm normalized name: Progesterone
DrugBank: Progesterone (DB00396)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Progesterone-releasing devices (various doses)
Trial: 31038562
Drug: sitagliptin 100
RxNorm normalized name: SITagliptin 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: sitagliptin 100 mg per day + metformin + insulin glargine
Trial: 31038562
Drug: voglibose 0.2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: voglibose 0.2 mg three times daily + metformin + insulin glargine
Trial: 16703733
Drug: Tadalafil dosing
RxNorm normalized name: Tadalafil
DrugBank: Tadalafil (DB00820)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Tadalafil dosing instructions
Trial: 2884114
Drug: Fenoldopam mesylate
RxNorm normalized name: Fenoldopam Mesylate
DrugBank: Fenoldopam (DB00800)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Fenoldopam mesylate 100 mg under fed conditions
Trial: 2884114
Drug: Fenoldopam 24-hour
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fenoldopam 24-hour excretion under fed conditions
Trial: 2884114
Drug: SK&F 87782
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SK&F 87782 24-hour excretion under fed conditions
Trial: 28874948
Drug: Electronic prescriptions
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Electronic prescriptions (E-prescriptions)
Trial: 28874948
Drug: Handwritten prescriptions
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Handwritten prescriptions (HW)
Trial: 26892359
Drug: Oral midazolam
RxNorm normalized name: Midazolam
DrugBank: Midazolam (DB00683)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Oral midazolam 1 mg/kg (MS)
Trial: 9770938
Drug: Soaks and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Soaks and daily dressing changes
Trial: 1974071
Drug: Alpidem 50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alpidem 50 mg
Trial: 2574502
Drug: Alpidem 75
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alpidem 75 mg
Trial: 2901120
Drug: Alpidem 50-150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alpidem 50-150 mg/day for 3-4 weeks
Trial: 26717970
Drug: Ultrasound-guided subacromial
RxNorm normalized name: Autologous CD34+ cells isolated from mobilised peripheral blood by positive selection, modified by CRISPR/Cas9 (clustered regularly interspaced short palindromic repeats/CRISPR-associated protein 9) mediated gene editing consisting of a guide RNA (gRNA)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ultrasound-guided subacromial corticosteroid injection
Trial: 26717970
Drug: Blind subacromial
RxNorm normalized name: Io-Blend
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Blind subacromial corticosteroid injection
Trial: 30852837
Drug: Oxycodone (0.03
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oxycodone (0.03 mg/kg)
Trial: 28719554
Drug: Nonsurgical treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nonsurgical treatment with a figure‐of‐eight harness
Trial: 25492411
Drug: 150 µg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 150 µg corifollitropin alfa
Trial: 25829811
Drug: Atorvastatin group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atorvastatin group
Trial: 17257455
Drug: 1000 mg
RxNorm normalized name: bran 1000 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1000 mg of paracetamol combined with 60 mg of pseudoephedrine
Trial: 12734763
Drug: Trimipramine (300-400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Trimipramine (300-400 mg)
Trial: 12734763
Drug: Perazine (450-600
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Perazine (450-600 mg)
Trial: 1478201
Drug: Lamotrigine (LTG)
RxNorm normalized name: Lamotrigine
DrugBank: Lamotrigine (DB00555)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Lamotrigine (LTG) therapy for 12 weeks
Trial: 1478201
Drug: Chronic LTG
RxNorm normalized name: Chromic Chloride
DrugBank: Chromic chloride (DB09129)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Chronic LTG therapy
Trial: 6233622
Drug: zimelidine, a
FDA approved: no
EMA approved: no
PMDA approved: no
Description: zimelidine, a serotonin re‐uptake inhibitor
Trial: 6233622
Drug: imipramine, a
FDA approved: no
EMA approved: no
PMDA approved: no
Description: imipramine, a noradrenaline re‐uptake inhibitor
Trial: 31884206
Drug: Doxofylline 400
RxNorm normalized name: Doxofylline 400 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Doxofylline 400 mg t.i.d. for one year
Trial: 15569362
Drug: Pantoprazole 40
RxNorm normalized name: pantoprazole 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pantoprazole 40 mg b.i.d. (group A)
Trial: 2885190
Drug: Alfentanil infusion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alfentanil infusion at 50 micrograms kg‐1 hr‐1
Trial: 2885190
Drug: Alfentanil infusion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alfentanil infusion at 100 micrograms kg‐1 hr‐1
Trial: 2885190
Drug: Alfentanil infusion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alfentanil infusion continued for two hours post-operatively at 20 micrograms kg‐1 hr‐1
Trial: 26364041
Drug: Dexketoprofen 10
RxNorm normalized name: dexketoprofen
DrugBank: Dexketoprofen (DB09214)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexketoprofen 10 mg i.v.
Trial: 26364041
Drug: Dexketoprofen 50
RxNorm normalized name: dexketoprofen
DrugBank: Dexketoprofen (DB09214)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dexketoprofen 50 mg i.v.
Trial: 11296717
Drug: Various training
RxNorm normalized name: various
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Various training procedures in the C‐G Arena
Trial: 11296717
Drug: C‐G Arena
FDA approved: no
EMA approved: no
PMDA approved: no
Description: C‐G Arena procedures
Trial: 8287862
Drug: Sulfadoxine-pyrimethamine (single
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sulfadoxine-pyrimethamine (single curative dose)
Trial: 31350236
Drug: Aclidinium bromide
RxNorm normalized name: Aclidinium Bromide
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Aclidinium bromide (Acli-BID) administered twice daily for 8 weeks
Trial: 31350236
Drug: Tiotropium bromide
RxNorm normalized name: Tiotropium Bromide
DrugBank: Tiotropium (DB01409)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Tiotropium bromide hydrate (Tio-QD) administered once daily for 8 weeks
Trial: 24142633
Drug: 15 mg
RxNorm normalized name: papain 15 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 15 mg of pioglitazone daily
Trial: 15307518
Drug: Specific immunotherapy
RxNorm normalized name: Pacific halibut
DrugBank: Pacific halibut (DB10616)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Specific immunotherapy with Allergovit or Novo Helisen Depot for 3 years
Trial: 12027048
Drug: Neuroleptic medications
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Neuroleptic medications
Trial: 8342578
Drug: Intranasal dDAVP
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intranasal dDAVP (20-40 micrograms according to body weight)
Trial: 8342578
Drug: Intravenous dDAVP
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous dDAVP (2-4 micrograms according to body weight)
Trial: 24699555
Drug: Normocaloric group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Normocaloric group (100% of daily energy expenditure)
Trial: 24699555
Drug: Hypocaloric group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hypocaloric group (50% of daily energy expenditure)
Trial: 17852143
Drug: Conjugated equine
RxNorm normalized name: Conjugated equine estrogens
DrugBank: Conjugated estrogens (DB00286)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Conjugated equine estrogens 0.625 mg (CEE, n=24)
Trial: 17852143
Drug: Conjugated equine
RxNorm normalized name: Conjugated equine estrogens
DrugBank: Conjugated estrogens (DB00286)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Conjugated equine estrogens + medroxyprogesterone acetate 5 mg (CEE/MPA, n=34)
Trial: 17852143
Drug: 17beta‐estradiol 1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 17beta‐estradiol 1 mg + norethisterone acetate 0.5 mg (E2/NETA, n=66)
Trial: 17852143
Drug: Tibolone 2.5
RxNorm normalized name: tibolone 2.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tibolone 2.5 mg (n=24)
Trial: 12145035
Drug: Large-Dose Aprotinin
RxNorm normalized name: Aprotinin
DrugBank: Aprotinin (DB06692)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Large-Dose Aprotinin
Trial: 7472817
Drug: Placebo tablet,
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo tablet, twice daily
Trial: 6098051
Drug: icosapentaenoic acid
RxNorm normalized name: Icosapentaenoic acid
DrugBank: Icosapent (DB00159)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: icosapentaenoic acid (20:5n‐3) 150 mg/day for one month
Trial: 9788828
Drug: Losartan (L)
DrugBank: Losartan (DB00678)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Losartan (L) 50 mg/d
Trial: 9770962
Drug: Methotrexate (30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methotrexate (30 mg a week i.v. in hospital, 7-10 mg a week as maintenance)
Trial: 3282826
Drug: 2,000 microgram
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2,000 microgram per day dose of beclomethasone dipropionate aerosol (BDP)
Trial: 31273505
Drug: Non-intervention group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Non-intervention group receiving the same CRC education handbook only at discharge preparation
Trial: 29357331
Drug: Pulsed fluoroscopy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pulsed fluoroscopy with 8 pulses per second (medium‐dose)
Trial: 29357331
Drug: Pulsed fluoroscopy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pulsed fluoroscopy with one pulse per second (low‐dose)
Trial: 29357331
Drug: Continuous mode
RxNorm normalized name: Ivy Dry Super Continuous Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous mode fluoroscopy (high‐dose)
Trial: 20160654
Drug: Candesartan cilexetil
RxNorm normalized name: Candesartan Cilexetil
DrugBank: Candesartan cilexetil (DB00796)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Candesartan cilexetil 0.05 mg/kg per day
Trial: 24569045
Drug: Agomelatine 25-50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Agomelatine 25-50 mg/d
Trial: 20496820
Drug: Bilateral injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Bilateral injection of 20 units of botulinum toxin into each side of the internal anal sphincter
Trial: 20496820
Drug: Posterior injection
RxNorm normalized name: posterior pituitary hormones
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Posterior injection of 25 units of botulinum toxin into the midline posteriorly
Trial: 9018513
Drug: Pseudoephedrine (120
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pseudoephedrine (120 mg)
Trial: 10436448
Drug: Low-molecular weight
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-molecular weight heparin (LMWH) therapy, 40 mg enoxaparin every 12 hours for 7 days, then 40 mg once daily for 3 months
Trial: 10436448
Drug: Oral anticoagulant
RxNorm normalized name: CPDA-1 Anticoagulant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral anticoagulant therapy (coumarin), standard unfractionated heparin followed by coumarin for 3 months
Trial: 10436448
Drug: Low-molecular weight
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low-molecular weight heparin (LMWH) therapy
Trial: 10436448
Drug: Oral anticoagulant
RxNorm normalized name: CPDA-1 Anticoagulant
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral anticoagulant therapy (coumarin)
Trial: 23924679
Drug: 200-mg tablets
RxNorm normalized name: pexidartinib 200 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 200-mg tablets
Trial: 8786960
Drug: 400-mg suspension
RxNorm normalized name: pentoxifylline 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 400-mg suspension
Trial: 2081489
Drug: nabumetone 1
RxNorm normalized name: nabumetone 1000 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: nabumetone 1 g at night
Trial: 2081489
Drug: slow release
RxNorm normalized name: Slow Release Iron
FDA approved: no
EMA approved: no
PMDA approved: no
Description: slow release diclofenac 100 mg at night
Trial: 31907645
Drug: QL1101 (3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: QL1101 (3 mg/kg, intravenously)
Trial: 31907645
Drug: Avastin® (3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Avastin® (3 mg/kg, intravenously)
Trial: 28099439
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of all three NSE measurements
Trial: 11079282
Drug: Oxandrolone 10
RxNorm normalized name: oxandrolone 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oxandrolone 10 mg twice/day for a maximum of 28 days
Trial: 7871058
Drug: ritanserin (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ritanserin (5 mg) + d-fenfluramine (30 mg)
Trial: 24673716
Drug: Low-dose cyclosporine
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose cyclosporine with short-term intensified EC-MPS dosing (2160 mg/day to week 6, 1440 mg/day thereafter) and corticosteroids
Trial: 24673716
Drug: Low-dose cyclosporine
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose cyclosporine with short-term intensified EC-MPS dosing
Trial: 24673716
Drug: Standard-dose cyclosporine
RxNorm normalized name: Cyclosporine
DrugBank: Cyclosporine (DB00091)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard-dose cyclosporine with standard EC-MPS dosing
Trial: 22469884
Drug: Micafungin (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Micafungin (50 mg/day i.v.)
Trial: 22469884
Drug: Itraconazole (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Itraconazole (5 mg/kg/day p.o.)
Trial: 18614570
Drug: Intravitreal pegaptanib
RxNorm normalized name: pegaptanib
DrugBank: Pegaptanib (DB04895)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravitreal pegaptanib sodium (0.3, 1, and 3 mg)
Trial: 16120074
Drug: Ziprasidone 40
RxNorm normalized name: ziprasidone 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ziprasidone 40 mg
Trial: 11808825
Drug: Cyclobenzaprine 5
RxNorm normalized name: cyclobenzaprine 5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cyclobenzaprine 5 mg oral dose
Trial: 11808825
Drug: Cyclobenzaprine 2.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cyclobenzaprine 2.5 to 10 mg tid
Trial: 11808825
Drug: Cyclobenzaprine multiple
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cyclobenzaprine multiple dosing
Trial: 2258157
Drug: Endoscopic sclerotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Endoscopic sclerotherapy (intravariceal and extravariceal injections of Polidocanol)
Trial: 23746562
Drug: Phosphatidylserine and
RxNorm normalized name: Phosphatidylserine
DrugBank: Phosphatidyl serine (DB00144)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Phosphatidylserine and caffeine (400 mg/d PS and 100 mg/d caffeine) for 2 weeks
Trial: 19341846
Drug: 10 mcg
RxNorm normalized name: D400, 10 mcg oral capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 mcg ethinyl estradiol (EE) daily during the hormone-free interval
Trial: 19341846
Drug: Placebo during
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo during the hormone-free interval
Trial: 9118978
Drug: Naloxone (N;
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Naloxone (N; 1.2 mg; 3 ml)
Trial: 9118978
Drug: Placebo (P;
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (P; 0.9% NaCl saline; 3 ml)
Trial: 12516995
Drug: Control (Hepatitis
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (Hepatitis B vaccine)
Trial: 3341259
Drug: Ascorbic acid
RxNorm normalized name: Ascorbic Acid
DrugBank: Ascorbic acid (DB00126)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ascorbic acid (50 mg) with Brazil nuts and peanuts
Trial: 26796612
Drug: Neostigmine-atropine combination
RxNorm normalized name: atropine / neostigmine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Neostigmine-atropine combination (Group N, n = 45)
Trial: 15975103
Drug: Perindopril/indapamide (2.0/0.625
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Perindopril/indapamide (2.0/0.625 mg daily, increasing to 4.0/1.25 mg daily after 3 months)
Trial: 15975103
Drug: Local standard
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Local standard therapy for glucose control
Trial: 14703409
Drug: SBN‐1 injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SBN‐1 injection at 1 x 10(12)VP
Trial: 6992844
Drug: 0.1% halcinonide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.1% halcinonide cream applied once daily
Trial: 31541768
Drug: SQ HDM
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SQ HDM SLIT tablet 10,000 Japanese Allergy Unit
Trial: 31309232
Drug: Genistein 400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Genistein 400 mg/kg
Trial: 31309232
Drug: Genistein (both
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Genistein (both doses)